Affiliation: Paulista School of Medicine, Federal University of São Paulo and Cellavita Pesquisas Cinetíficas Ltda.

Anderson Lucas Alievi has graduated in Biotechnology from Federal University of Latin American Integration (UNILA) and Ph.D. Student in UNIFESP. Currently, he is serving as a researcher at Cellavita Pesquisas Científicas Ltda. Anderson Alieve has expertise in cancer genetics and molecular biology with focus on the development of disruptive technology for thyroid cancer treatment, based on mesenchymal-stem cell-derived exosomes, as alterative therapy for anaplastic thyroid cancer.